All G Foods
All G Foods is a company.
Active
Updated: ·
Financial History
Total Raised
N/A
Valuation
N/A
Leadership Team
Key people at All G Foods.
All G Foods is a company.
Key people at All G Foods.
Key people at All G Foods.
All G Foods (also referred to as All G) is an Australian biotech startup founded in 2020 that produces bovine- and human-identical milk proteins, such as lactoferrin, using precision fermentation to create sustainable, animal-free alternatives to traditional dairy.[1][3][5] The company targets the dairy and nutrition industries, serving supplement makers, personal care brands, and food manufacturers by solving key challenges like dairy's high environmental impact, supply shortages, and limitations of plant-based substitutes that often lack dairy's nutritional profile, taste, and texture.[1][2] With recent $6.6 million funding, a joint venture with French dairy expert Armor Protéines, self-GRAS approval in the US for adult nutrition, and approvals in China, All G is scaling from pilot production to commercial launch of bovine lactoferrin in Q1 2026, followed by human lactoferrin, demonstrating strong growth momentum through partnerships and contract manufacturing in China and the US/Europe.[2]
All G was founded in 2020 by CEO Jan Pacas in Sydney, Australia, driven by his ambition to revolutionize the food industry with low-carbon, animal-free solutions after prior ventures in Flare and Mad Paws.[1][3] Pacas identified an opportunity to address planetary environmental issues and feed a growing population through precision fermentation of milk proteins, starting with dairy alternatives that match bovine and human profiles.[1][5] Early traction included pilot-scale validation with Döhler, winning FaBA Food and Beverage Startup of the Year, and a 4-year, $4 million project with UQ Ventures leveraging bio-reactor technology from the Australian Institute for Bioengineering and Nanotechnology to accelerate commercialization.[4]
All G rides the precision fermentation wave in alternative proteins, addressing dairy's environmental footprint amid global pressure for sustainable food systems and a population boom.[1] Timing is ideal as bovine lactoferrin demand outstrips supply from animal sources, enabling All G to integrate into existing markets via partners like Armor Protéines rather than creating demand from zero.[2] Favorable forces include advancing biotech infrastructure (e.g., bio-reactors), regulatory progress in key markets like the US and China, and investor interest in climate-friendly nutrition, as shown by their $6.6M raise.[2][4] The company influences the ecosystem by bridging biotech with traditional dairy, accelerating animal-free protein adoption and enabling "next-generation nutrition" for mass markets.[1]
All G is poised for rapid commercialization with bovine lactoferrin hitting markets in Q1 2026, leveraging JV synergies for quick revenue, followed by human lactoferrin expansion.[2] Trends like tightening sustainability regulations, precision fermentation cost reductions, and rising demand for bioactive proteins in infant formula, supplements, and functional foods will propel growth, potentially transforming dairy supply chains.[1][2] Their influence may evolve from niche innovator to scale player, reshaping nutrition for billions by filling supply gaps and proving animal-free proteins viable at commercial volumes—echoing their founding vision to feed the planet sustainably.[1]
